![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Asthma drug shows promise in treating diabetes, obesity
Amlexanox, a drug prescribed for asthma in Japan, also reverses obesity, diabetes and fatty...
Compound stimulates tumor-fighting protein in cancer therapy
A compound that stimulates the production of a tumor-fighting protein may improve the usefulness...
Fighting fat with fat: Stem cell discovery identifies potential obesity treatment
Ottawa scientists have discovered a trigger that turns muscle stem cells into brown fat,...
Low vitamin D levels may increase risk of Type 1 diabetes
Having adequate levels of vitamin D during young adulthood may reduce the risk of...
Shire Reaches Agreement in Principle With U.S. Government
Shire plc , today announced that it has reached an agreement in principle to...
GSK response to news article in The Guardian on UK legal proceedings related to...
Responding to a news article in The Guardian on UK legal proceedings related to...
Discrepant analyses of industry-sponsored clinical trials
Internal pharmaceutical company documents detailing the planned and completed analyses for clinical trials do...
Clinical trials with nonblinded outcome assessors have high observer bias
A new study of randomized clinical trials found significant observer bias toward a more...
Amgen’s full year 2012 revenues increased 11 percent to $17.3 billion
Amgen has announced financial results for the fourth quarter and full year of 2012....
New drug protects against side effects of chemotherapy
A drug developed at Linköping University in Sweden protects against the side effects of...